These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 32095594)

  • 21. Single institution's dosimetry and IGRT analysis of prostate SBRT.
    Wu QJ; Li T; Yuan L; Yin FF; Lee WR
    Radiat Oncol; 2013 Sep; 8():215. PubMed ID: 24034234
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CBCT evaluation of inter- and intra-fraction motions during prostate stereotactic body radiotherapy: a technical note.
    Jmour O; Benna M; Champagnol P; Ben Mrad M; Hamrouni A; Obeid L; Lahmamssi C; Bousarsar A; Vial N; Rehailia-Blanchard A; Sotton S; Lan M; Langrand-Escure J; Vallard A; Magné N
    Radiat Oncol; 2020 Apr; 15(1):85. PubMed ID: 32307017
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inter- and intra-observer variability in contouring of the prostate gland on planning computed tomography and cone beam computed tomography.
    Choi HJ; Kim YS; Lee SH; Lee YS; Park G; Jung JH; Cho BC; Park SH; Ahn H; Kim CS; Yi SY; Ahn SD
    Acta Oncol; 2011 May; 50(4):539-46. PubMed ID: 21391773
    [TBL] [Abstract][Full Text] [Related]  

  • 24. PTV margin definition in hypofractionated IGRT of localized prostate cancer using cone beam CT and orthogonal image pairs with fiducial markers.
    Oehler C; Lang S; Dimmerling P; Bolesch C; Kloeck S; Tini A; Glanzmann C; Najafi Y; Studer G; Zwahlen DR
    Radiat Oncol; 2014 Nov; 9():229. PubMed ID: 25384898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A clinical study comparing polymer and gold fiducials for prostate cancer radiotherapy.
    Lim Joon D; Berry C; Harris B; Tacey M; Smith D; Lawrentschuk N; Schneider ME; Fraser O; Hall M; Chao M; Foroudi F; Jenkins T; Angus D; Wada M; Sengupta S; Khoo V
    Front Oncol; 2022; 12():1023288. PubMed ID: 36818674
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Improved clinical outcomes with high-dose image guided radiotherapy compared with non-IGRT for the treatment of clinically localized prostate cancer.
    Zelefsky MJ; Kollmeier M; Cox B; Fidaleo A; Sperling D; Pei X; Carver B; Coleman J; Lovelock M; Hunt M
    Int J Radiat Oncol Biol Phys; 2012 Sep; 84(1):125-9. PubMed ID: 22330997
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of a commercial DIR platform for contour propagation in prostate cancer patients treated with IMRT/VMAT.
    Hammers JE; Pirozzi S; Lindsay D; Kaidar-Person O; Tan X; Chen RC; Das SK; Mavroidis P
    J Appl Clin Med Phys; 2020 Feb; 21(2):14-25. PubMed ID: 32058663
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Observer uncertainties of soft tissue-based patient positioning in IGRT.
    Hirose TA; Arimura H; Fukunaga JI; Ohga S; Yoshitake T; Shioyama Y
    J Appl Clin Med Phys; 2020 Feb; 21(2):73-81. PubMed ID: 31957964
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Initial results for patient setup verification using transperineal ultrasound and cone beam CT in external beam radiation therapy of prostate cancer.
    Richter A; Polat B; Lawrenz I; Weick S; Sauer O; Flentje M; Mantel F
    Radiat Oncol; 2016 Nov; 11(1):147. PubMed ID: 27825386
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Geometric discrepancy of image-guided radiation therapy in patients with prostate cancer without implanted fiducial markers using a commercial pseudo-CT generation method.
    Kan H; Eguchi Y; Tsuchiya T; Kondo T; Kitagawa Y; Mekata Y; Fukuma H; Yoshida R; Kasai H; Kunitomo H; Hirose Y; Shibamoto Y
    Phys Med Biol; 2019 Mar; 64(6):06NT01. PubMed ID: 30695772
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Influence of daily imaging on plan quality and normal tissue toxicity for prostate cancer radiotherapy.
    Bell K; Heitfeld M; Licht N; Rübe C; Dzierma Y
    Radiat Oncol; 2017 Jan; 12(1):7. PubMed ID: 28069053
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cone beam CT-based dose accumulation and analysis of delivered dose to the dominant intraprostatic lesion in primary radiotherapy of prostate cancer.
    Tamihardja J; Cirsi S; Kessler P; Razinskas G; Exner F; Richter A; Polat B; Flentje M
    Radiat Oncol; 2021 Oct; 16(1):205. PubMed ID: 34702305
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of CBCT-based prostate setup correction strategies and impact of rectal distension.
    Boydev C; Taleb-Ahmed A; Derraz F; Peyrodie L; Thiran JP; Pasquier D
    Radiat Oncol; 2015 Apr; 10():83. PubMed ID: 25890308
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A comparative assessment of prostate positioning guided by three-dimensional ultrasound and cone beam CT.
    Li M; Ballhausen H; Hegemann NS; Ganswindt U; Manapov F; Tritschler S; Roosen A; Gratzke C; Reiner M; Belka C
    Radiat Oncol; 2015 Apr; 10():82. PubMed ID: 25890013
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Fiducial markers implanted during prostate brachytherapy for guiding conformal external beam radiation therapy.
    Welsh JS; Berta C; Borzillary S; Sam C; Shickell D; Nobile L; Greenberg M; Weiss S; Detorie N
    Technol Cancer Res Treat; 2004 Aug; 3(4):359-64. PubMed ID: 15270586
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Daily dosimetric variation between image-guided volumetric modulated arc radiotherapy and MR-guided daily adaptive radiotherapy for prostate cancer stereotactic body radiotherapy.
    Nicosia L; Sicignano G; Rigo M; Figlia V; Cuccia F; De Simone A; Giaj-Levra N; Mazzola R; Naccarato S; Ricchetti F; Vitale C; Ruggieri R; Alongi F
    Acta Oncol; 2021 Feb; 60(2):215-221. PubMed ID: 32945701
    [TBL] [Abstract][Full Text] [Related]  

  • 37. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analyses of the factors influencing the accuracy of three-dimensional ultrasound in comparison with cone-beam CT in image-guided radiotherapy for prostate cancer with or without pelvic lymph node irradiation.
    Zhou S; Luo L; Li J; Lin M; Chen L; Shao J; Lu S; Ma Y; Zhang Y; Chen W; Liu M; Liu S; He L
    Radiat Oncol; 2019 Jan; 14(1):22. PubMed ID: 30696488
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Phantom and in-vivo measurements of dose exposure by image-guided radiotherapy (IGRT): MV portal images vs. kV portal images vs. cone-beam CT.
    Walter C; Boda-Heggemann J; Wertz H; Loeb I; Rahn A; Lohr F; Wenz F
    Radiother Oncol; 2007 Dec; 85(3):418-23. PubMed ID: 18023491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cone-beam CT-based adaptive planning improves permanent prostate brachytherapy dosimetry: An analysis of 1266 patients.
    Westendorp H; Hoekstra CJ; Immerzeel JJ; van de Pol SM; Niël CG; Kattevilder RA; Nuver TT; Minken AW; Moerland MA
    Med Phys; 2017 Apr; 44(4):1257-1267. PubMed ID: 28192614
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.